ArticleCell death and differentiation2026
TRIM17 downregulation modulates CRPC progression and enzalutamide resistance by derepressing BCL2 expression via the p53-dependent and p53-independent pathways.
Zhi Shang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.